secwatch.observer — SEC 8-K summary
======================================

Issuer:     Teladoc Health, Inc. (TDOC)
CIK:        0001477449
Form:       8-K
Filed at:   2023-04-26T23:59:59+00:00
Accession:  0001558370-23-006823
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teladoc Q1 revenue $629M (+11% YoY); net loss $0.42/sh; guides Q2 rev $635-660M
-------------------------------------------------------------------------------

- Revenue $629.2M (+11% YoY); Integrated Care $350M (+5%), BetterHelp $279M (+21%).
- Net loss $69.2M ($0.42/sh) vs $6.67B loss in Q1 2022 which included $6.6B goodwill impairment.
- Adjusted EBITDA $52.8M (-3% YoY); Integrated Care segment adj. EBITDA +51% to $35.1M, BetterHelp -41% to $17.6M.
- Q2 2023 guidance: rev $635-660M, adj. EBITDA $60-68M, net loss per share ($0.55)-($0.45).
- Full year 2023 guidance: rev $2.575-2.675B, adj. EBITDA $285-325M, net loss per share ($1.70)-($1.25).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477449/000155837023006823/0001558370-23-006823-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477449/000155837023006823/tdoc-20230426x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-006823

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer